Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
2.
Dermatologie (Heidelb) ; 73(10): 804-808, 2022 Oct.
Artigo em Alemão | MEDLINE | ID: mdl-35428953

RESUMO

Characteristic skin changes lead to diagnosis of pseudoxanthoma elasticum (PXE), an ectopic mineralization disorder, involving primarily the skin, eyesight, and arterial vessels. Early recognition is crucial for timely treatment of extracutaneous complications. We hereby report a series of four cases of PXE with pathognomonic skin lesions and a broad spectrum of systemic complications.


Assuntos
Pseudoxantoma Elástico , Dermatologistas , Humanos , Proteínas Associadas à Resistência a Múltiplos Medicamentos , Pseudoxantoma Elástico/diagnóstico , Pele/patologia
4.
J Dtsch Dermatol Ges ; 18(1): 27-32, 2020 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-31671255

RESUMO

BACKGROUND AND OBJECTIVES: Dermatoscopy may be hindered by body hair, and the development of an automated hair removal algorithm (AuHRA) might improve the diagnostic accuracy. However, the physicians' exact level of hindrance and the clinical benefit attained by AuHRA has not been assessed. The objectives of this study are to quantify the physicians' level of hindrance by body hair and the level of improvement in the visibility of underlying dermatoscopic patterns after application of AuHRA to digital images of hair-covered nevi. PATIENTS AND METHODS: A cross-sectional reader study including 59 sets of dermatoscopic images of benign nevi that were presented to six dermatologists. Each set included three images of one individual nevus (unshaved/physically shaved/digitally shaved with AuHRA), which were compared to each other within each set to assess the level of improvement caused by hair removal. RESULTS: In comparison to unshaved lesions, dermatologists attributed the highest mean level of improvement to a physical shave (+1.36, p < 0.001) followed by AuHRA's digital shave (+0.79, p < 0.001). The majority of dermatologists considered the application of AuHRA as helpful and confirmed a medical need. CONCLUSIONS: The dermatologists in our study confirmed a substantial impairment of the dermatoscopic examination by body hair. We demonstrated a clinical benefit attained by AuHRA in comparison to unshaved or physically shaved lesions.


Assuntos
Algoritmos , Remoção de Cabelo/métodos , Nevo/diagnóstico , Neoplasias Cutâneas/diagnóstico , Estudos Transversais , Dermoscopia/métodos , Diagnóstico Diferencial , Humanos , Exame Físico
9.
Dermatol Ther ; 29(6): 419-423, 2016 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-27550573

RESUMO

Topical steroids are effective in treating bullous pemphigoid (BP). Autoantibodies against BP180 are related to disease activity, but correlation of these autoantibodies with response to topical steroid therapy has not yet been clearly evaluated. We investigate the usefulness of close and early monitoring of autoantibodies against BP180 and BP230 for assessment of response to therapy and early detection of therapeutic failure in BP patients treated topically. In eight BP patients under treatment with topical or systemic steroid therapy we retrospectively evaluated clinical course and autoantibodies against BP180 and BP230 as well as indirect immunofluorescence titres (IIF). Data were included at diagnosis, during hospitalization and follow-ups. Autoantibodies against BP180 parallel disease activity in all topically and as well as systemically treated patients. Autoantibodies against BP230 correlated in five out of eight patients. Autoantibodies directed against BP180 and, to a lesser degree, against BP230 correlate with the clinical course of topically treated BP patients. Monitoring autoantibodies against BP180 is a useful tool to evaluate the efficacy of topical therapy in BP.


Assuntos
Corticosteroides/administração & dosagem , Autoanticorpos/sangue , Autoantígenos/imunologia , Distonina/imunologia , Imunoglobulina G/sangue , Colágenos não Fibrilares/imunologia , Penfigoide Bolhoso/tratamento farmacológico , Administração Cutânea , Adulto , Idoso , Idoso de 80 Anos ou mais , Biomarcadores/sangue , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Penfigoide Bolhoso/sangue , Penfigoide Bolhoso/diagnóstico , Penfigoide Bolhoso/imunologia , Valor Preditivo dos Testes , Estudos Retrospectivos , Fatores de Tempo , Resultado do Tratamento , Colágeno Tipo XVII
11.
Biomarkers ; 15(6): 523-32, 2010 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-20528622

RESUMO

OBJECTIVE: Besides persisting high pulmonary arterial pressure and increased pulmonary vascular resistance, remodelling of pulmonary tissues and subsequently the right heart are the key pathomechanisms of pulmonary hypertension (PH). Extracellular matrix maintenance in this context plays a central role. METHODS: We tested the hypothesis that plasma concentration of matrix metalloproteinase (MMP)-2, tissue inhibitor of matrix metalloproteinases (TIMP)-4 and tenascin C (TNC) might be useful as biomarkers for assessing the severity of PH. Therefore, the concentrations of MMP-2, TIMP-4, TNC and N-terminal b-type natriuretic peptide (NT-proBNP) of 36 PH patients were compared with those of 44 age- and gender-matched healthy volunteers. Additionally, lung function, 6-min walk distance and right heart function were assessed. RESULTS: In PH patients, significantly elevated plasma levels of MMP-2, TIMP-4, TNC and NT-proBNP were detected. In particular, TIMP-4 was significantly increased in patients with higher NYHA classification, and in patients with severe right ventricular hypertrophy. CONCLUSION: Monitoring of plasma TIMP-4 and to a lesser extent of MMP-2 and TNC levels in PH patients might help to assess the beneficial effects of PH pharmacotherapy on tissue remodelling.


Assuntos
Hipertensão Pulmonar/patologia , Adulto , Idoso , Biomarcadores/sangue , Cateterismo Cardíaco , Ecocardiografia , Teste de Esforço , Feminino , Humanos , Hipertensão Pulmonar/etiologia , Imunoensaio , Pulmão/metabolismo , Pulmão/patologia , Masculino , Metaloproteinase 2 da Matriz/sangue , Pessoa de Meia-Idade , Miocárdio/metabolismo , Miocárdio/patologia , Peptídeo Natriurético Encefálico/sangue , Fragmentos de Peptídeos/sangue , Testes de Função Respiratória , Inibidores Teciduais de Metaloproteinases/sangue , Fatores de Necrose Tumoral/sangue , Caminhada/fisiologia , Inibidor Tecidual 4 de Metaloproteinase
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA